Citadel Advisors’s GP-Act III Acquisition Corp GPAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$186K Buy
17,172
+2,263
+15% +$24.4K ﹤0.01% 11476
2025
Q4
$160K Sell
14,909
-3,857
-21% -$41.1K ﹤0.01% 11242
2025
Q3
$199K Buy
18,766
+722
+4% +$7.63K ﹤0.01% 11273
2025
Q2
$190K Buy
18,044
+6,266
+53% +$65.5K ﹤0.01% 10722
2025
Q1
$122K Buy
11,778
+1,638
+16% +$16.8K ﹤0.01% 11187
2024
Q4
$103K Buy
+10,140
New +$102K ﹤0.01% 11441

Other funds holding GPAT

Citadel Advisors's GPAT Position: Q1 2026 in Review

Citadel Advisors increased its GP-Act III Acquisition Corp (GPAT) stake by 15% in Q1 2026, buying an estimated $24.4K and bringing the position to 17,172 shares worth $186K. The position accounts for ﹤0.01% of the portfolio, ranked #11476.

Citadel Advisors first reported a position in GPAT in Q4 2024 and has held it in 6 quarters since. The position peaked at $199K in Q3 2025. 51 funds tracked by Wall St. Rank hold GPAT as of Q1 2026.

  • Citadel Advisors held 17,172 shares of GP-Act III Acquisition Corp worth $186K as of Q1 2026.
  • Citadel Advisors bought 2,263 GP-Act III Acquisition Corp shares in Q1 2026, an estimated $24.4K.
  • GP-Act III Acquisition Corp made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #11476 holding.
  • Citadel Advisors first reported a position in GP-Act III Acquisition Corp in Q4 2024 and has held it in 6 quarters since.
  • Citadel Advisors's GP-Act III Acquisition Corp position peaked at $199K in Q3 2025.
  • 51 funds tracked by Wall St. Rank held GP-Act III Acquisition Corp as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.